Multiple Vertebral Fractures After Denosumab Discontinuation: <scp>FREEDOM</scp> and <scp>FREEDOM</scp> Extension Trials Additional Post Hoc Analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses

Published:2022-10-12 Issue:11 Volume:37 Page:2112-2120
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Cosman Felicia¹^ORCID,Huang Shuang²,McDermott Michele²,Cummings Steven R.³

Affiliation:

1. Division of Endocrinology/Department of Medicine Columbia University New York NY USA

2. Amgen Inc. Thousand Oaks CA USA

3. San Francisco Coordinating Center California Pacific Medical Center Research Institute and University of California San Francisco CA USA

Funder

Amgen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4705

Reference26 articles.

1. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

2. Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

3. Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study

4. Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis

5. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of multiple vertebral fractures after denosumab discontinuation under treatment with romosozumab. A case-report;Joint Bone Spine;2024-09

2. The role of Clec11a in bone construction and remodeling;Frontiers in Endocrinology;2024-08-12

3. One versus 2 years of alendronate following denosumab: the CARD extension;Osteoporosis International;2024-08-07

4. Os tumoral;Revue du Rhumatisme;2024-08

5. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024;Journal of Bone and Mineral Research;2024-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3